Follow
Tim Campellone, PhD
Tim Campellone, PhD
Woebot Health
Verified email at woebothealth.com
Title
Cited by
Cited by
Year
Efficacy of PRIME, a mobile app intervention designed to improve motivation in young people with schizophrenia
DA Schlosser, TR Campellone, B Truong, K Etter, S Vergani, K Komaiko, ...
Schizophrenia bulletin 44 (5), 1010-1020, 2018
1772018
Defeatist performance beliefs, negative symptoms, and functional outcome in schizophrenia: a meta-analytic review
TR Campellone, AH Sanchez, AM Kring
Schizophrenia bulletin 42 (6), 1343-1352, 2016
1452016
Feasibility of PRIME: a cognitive neuroscience-informed mobile app intervention to enhance motivated behavior and improve quality of life in recent onset schizophrenia
D Schlosser, T Campellone, D Kim, B Truong, S Vergani, C Ward, ...
JMIR research protocols 5 (2), e5450, 2016
1202016
Social motivation in schizophrenia: How research on basic reward processes informs and limits our understanding
D Fulford, T Campellone, DE Gard
Clinical Psychology Review 63, 12-24, 2018
1132018
Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis
DA Schlosser, TR Campellone, B Biagianti, KL Delucchi, DE Gard, ...
Schizophrenia research 169 (1-3), 204-208, 2015
1002015
Who do you trust? The impact of facial emotion and behaviour on decision making
TR Campellone, AM Kring
Cognition & emotion 27 (4), 603-620, 2013
972013
The feasibility, acceptability, and outcomes of PRIME‐D: A novel mobile intervention treatment for depression
DA Schlosser, TR Campellone, B Truong, JA Anguera, S Vergani, ...
Depression and anxiety 34 (6), 546-554, 2017
512017
The power to resist: The relationship between power, stigma, and negative symptoms in schizophrenia
TR Campellone, JM Caponigro, AM Kring
Psychiatry research 215 (2), 280-285, 2014
512014
Anticipated pleasure for positive and negative social interaction outcomes in schizophrenia
TR Campellone, AM Kring
Psychiatry research 259, 203-209, 2018
362018
Barriers and facilitators to mobile application use during PTSD treatment: Clinician adoption of PE coach.
GM Reger, KC Browne, TR Campellone, C Simons, E Kuhn, JC Fortney, ...
Professional Psychology: Research and Practice 48 (6), 510, 2017
342017
Using social outcomes to inform decision-making in schizophrenia: Relationships with symptoms and functioning.
TR Campellone, AJ Fisher, AM Kring
Journal of abnormal psychology 125 (2), 310, 2016
332016
A positive emotion regulation intervention for bipolar I disorder: Treatment development and initial outcomes
JM Painter, J Mote, AD Peckham, EH Lee, TR Campellone, JG Pearlstein, ...
General hospital psychiatry 61, 96-103, 2019
312019
Social motivation in people with recent-onset schizophrenia spectrum disorders
TR Campellone, B Truong, D Gard, DA Schlosser
Journal of psychiatric research 99, 96-103, 2018
302018
Feasibility of PRIME: a cognitive neuroscience-informed mobile app intervention to enhance motivated behavior and improve quality of life in recent onset schizophrenia. JMIR …
D Schlosser, T Campellone, D Kim, B Truong, S Vergani, C Ward, ...
29
High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions
JM Painter, CA Malte, AD Rubinsky, TR Campellone, AK Gilmore, JS Baer, ...
The American journal of drug and alcohol abuse 44 (3), 386-394, 2018
272018
Striatal intrinsic reinforcement signals during recognition memory: relationship to response bias and dysregulation in schizophrenia
DH Wolf, RT Gerraty, TD Satterthwaite, J Loughead, T Campellone, ...
Frontiers in behavioral neuroscience 5, 81, 2011
272011
Negative symptoms in psychometrically defined schizotypy: The role of depressive symptoms
TR Campellone, O Elis, J Mote, AH Sanchez, AM Kring
Psychiatry Research 240, 181-186, 2016
262016
Emotion perception in schizophrenia: context matters
AM Kring, TR Campellone
Emotion Review 4 (2), 182-186, 2012
252012
Appropriate controls for digital therapeutic clinical trials: a narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial …
J Lutz, E Offidani, L Taraboanta, SE Lakhan, TR Campellone
Frontiers in Digital Health 4, 823977, 2022
212022
A smartphone-based intervention as an adjunct to standard-of-care treatment for schizophrenia: randomized controlled trial
SN Ghaemi, O Sverdlov, J van Dam, T Campellone, R Gerwien
JMIR formative research 6 (3), e29154, 2022
202022
The system can't perform the operation now. Try again later.
Articles 1–20